In Vivo Tracking of Tissue Engineered Constructs

被引:27
|
作者
Gil, Carmen J. [1 ,2 ]
Tomov, Martin L. [1 ,2 ]
Theus, Andrea S. [1 ,2 ]
Cetnar, Alexander [1 ,2 ]
Mahmoudi, Morteza [3 ,4 ]
Serpooshan, Vahid [1 ,2 ,5 ,6 ]
机构
[1] Emory Univ, Sch Med, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA
[2] Georgia Inst Technol, Atlanta, GA 30322 USA
[3] Michigan State Univ, Precis Hlth Program, E Lansing, MI 48824 USA
[4] Michigan State Univ, Dept Radiol, E Lansing, MI 48824 USA
[5] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30309 USA
[6] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA
基金
美国国家科学基金会;
关键词
in vivo imaging; tissue engineering; 3D bioprinting; additive manufacturing; scaffold tracking; magnetic resonant imaging (MRI); computed tomography (CT); ultrasound; fluorescence spectroscopy; bioluminescence; optical coherence tomography; photoacoustic imaging; magnetic-particle imaging; multimodal imaging; X-RAY ANGIOGRAPHY; MAGNETIC-RESONANCE ANGIOGRAPHY; GOLD NANOPARTICLES; IMAGING TECHNOLOGIES; STEM-CELLS; QUANTITATIVE ASSESSMENT; MECHANICAL-PROPERTIES; HYDROGEL DEGRADATION; COMPUTED-TOMOGRAPHY; CONTRAST AGENTS;
D O I
10.3390/mi10070474
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
To date, the fields of biomaterials science and tissue engineering have shown great promise in creating bioartificial tissues and organs for use in a variety of regenerative medicine applications. With the emergence of new technologies such as additive biomanufacturing and 3D bioprinting, increasingly complex tissue constructs are being fabricated to fulfill the desired patient-specific requirements. Fundamental to the further advancement of this field is the design and development of imaging modalities that can enable visualization of the bioengineered constructs following implantation, at adequate spatial and temporal resolution and high penetration depths. These in vivo tracking techniques should introduce minimum toxicity, disruption, and destruction to treated tissues, while generating clinically relevant signal-to-noise ratios. This article reviews the imaging techniques that are currently being adopted in both research and clinical studies to track tissue engineering scaffolds in vivo, with special attention to 3D bioprinted tissue constructs.
引用
收藏
页数:23
相关论文
共 50 条
  • [1] Fabrication and in vivo perfusion of vascularized tissue engineered constructs
    Campbell, Rachel
    Hernandez, Karina A.
    Boyko, Tatiana
    Delnero, Peter
    Garcia, Daniel
    Reiffel, Alyssa J.
    Spector, Jason A.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2013, 217 (03) : S156 - S157
  • [2] Fabrication and In Vivo Microanastomosis of Vascularized Tissue-Engineered Constructs
    Hooper, Rachel Campbell
    Hernandez, Karina A.
    Boyko, Tatiana
    Harper, Alice
    Joyce, Jeremiah
    Golas, Alyssa R.
    Spector, Jason A.
    TISSUE ENGINEERING PART A, 2014, 20 (19-20) : 2711 - 2719
  • [3] An Overview of Methods for the In Vivo Evaluation of Tissue-Engineered Skin Constructs
    Lammers, Gerwen
    Verhaegen, Pauline D. H. M.
    Ulrich, Magda M. W.
    Schalkwijk, Joost
    Middelkoop, Esther
    Weiland, Daniela
    Nillesen, Suzan T. M.
    Van Kuppevelt, Toin H.
    Daamen, Willeke F.
    TISSUE ENGINEERING PART B-REVIEWS, 2011, 17 (01) : 33 - 55
  • [4] Development of in vivo μCT evaluation of neovascularisation in tissue engineered bone constructs
    Bolland, B. J. R. F.
    Kanczler, J. M.
    Dunlop, D. G.
    Oreffo, R. O. C.
    BONE, 2008, 43 (01) : 195 - 202
  • [5] Vascularization of tissue engineered constructs
    Pullens, R. A. A.
    Bouten, C. V. C.
    Baaijens, F. P. T.
    Post, M. J.
    JOURNAL OF VASCULAR RESEARCH, 2006, 43 : 77 - 77
  • [6] Confocal fluorometer for diffusion tracking in 3D engineered tissue constructs
    Daly, D.
    Zilioli, A.
    Tan, N.
    Buttenschoen, K.
    Chikkanna, B.
    Reynolds, J.
    Marsden, B.
    Hughes, C.
    THREE-DIMENSIONAL AND MULTIDIMENSIONAL MICROSCOPY: IMAGE ACQUISITION AND PROCESSING XXIII, 2016, 9713
  • [7] Tissue-engineered skin substitutes:: from in vitro constructs to in vivo applications
    Auger, FA
    Berthod, F
    Moulin, W
    Pouliot, R
    Germain, L
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2004, 39 : 263 - 275
  • [8] Ischemia is a prime but not the only cause of hMSC death in tissue engineered constructs in vivo
    Logeart-Avramoglou, D.
    Becquart, P.
    Cambon-Binder, A.
    Bourguignon, M.
    Bensidhoum, M.
    Petite, H.
    JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2012, 6 : 375 - 375
  • [9] Decelerated vascularization in tissue-engineered constructs in association with diabetes mellitus in vivo
    Schumann, Paul
    Lindhorst, Daniel
    Kampmann, Andreas
    Gellrich, Nils-Claudius
    Krone-Wolf, Sonja
    Meyer-Lindenberg, Andrea
    von See, Constantin
    Gander, Thomas
    Lanzer, Martin
    Rucker, Martin
    Essig, Harald
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (07) : 855 - 864
  • [10] CHALLENGES OF CRYOPRESERVATION OF TISSUE ENGINEERED CONSTRUCTS
    Kuleshova, Lilia
    CRYOLETTERS, 2009, 30 (01) : 76 - 77